# Aurograb and Vancomycin in MRSA Infection

> **NCT00217841** · PHASE3 · COMPLETED · sponsor: **NeuTec Pharma** · enrollment: 180 (—)

## Conditions studied

- Staphylococcal Infections

## Interventions

- **DRUG:** Aurograb

## Key facts

- **NCT ID:** NCT00217841
- **Lead sponsor:** NeuTec Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 180 (—)
- **Last updated:** 2006-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00217841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00217841, "Aurograb and Vancomycin in MRSA Infection". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00217841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*